These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 15163320)

  • 1. Splenectomy results in patients with idiopathic thrombocytopenic purpura: 10 years of experience in Turgut Ozal Medical Center.
    Ismet A; Irfan K; Emin K; AlI EM; Ramazan U; Mustafa B; Onur O
    Clin Lab Haematol; 2004 Jun; 26(3):211-4. PubMed ID: 15163320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
    Schiavotto C; Castaman G; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
    Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
    Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
    Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of patients with idiopathic thrombocytopenic purpura from Eastern Anatolia.
    Kaya E; Erkurt MA; Aydogdu I; Kuku I; Ozhan O; Oner RI; Ulutas O
    Med Princ Pract; 2007; 16(2):100-6. PubMed ID: 17303943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to splenectomy is durable after a certain point in time in adult patients with chronic immune thrombocytopenic purpura.
    Johansson E; Engervall P; Landgren O; Grimfors G; Widell S; Rezai S; Björkholm M
    Eur J Haematol; 2006 Jul; 77(1):61-6. PubMed ID: 16573739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.
    Winde G; Schmid KW; Lügering N; Fischer R; Brandt B; Berns T; Bünte H
    J Am Coll Surg; 1996 Dec; 183(6):565-74. PubMed ID: 8957458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of splenectomy in immune thrombocytopenic purpura: long-term results of 402 cases.
    Vianelli N; Galli M; de Vivo A; Intermesoli T; Giannini B; Mazzucconi MG; Barbui T; Tura S; Baccaranion M;
    Haematologica; 2005 Jan; 90(1):72-7. PubMed ID: 15642672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura.
    Vancine-Califani SM; De Paula EV; Ozelo MC; Orsi FL; Fabri DR; Annichino-Bizzacchi JM
    Platelets; 2008 Nov; 19(7):489-95. PubMed ID: 18979360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP).
    Schwartz J; Leber MD; Gillis S; Giunta A; Eldor A; Bussel JB
    Am J Hematol; 2003 Feb; 72(2):94-8. PubMed ID: 12555211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura: outcome and long-term results.
    Bresler L; Guerci A; Brunaud L; Ayav A; Sebbag H; Tortuyaux JM; Lederlin P; Boissel P
    World J Surg; 2002 Jan; 26(1):111-4. PubMed ID: 11898043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenectomy for idiopathic thrombocytopenic purpura: a five-year retrospective review.
    Gibson M; Sehon JK; White S; Zibari GB; Johnson LW
    Am Surg; 2000 Oct; 66(10):952-4; discussion 955. PubMed ID: 11261623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic splenectomy for idiopathic thrombocytopenic purpura (ITP).
    Pace DE; Chiasson PM; Schlachta CM; Mamazza J; Poulin EC
    Surg Endosc; 2003 Jan; 17(1):95-8. PubMed ID: 12360373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
    Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
    Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenectomy for immune thrombocytopenic purpura: long-term results and treatment of postsplenectomy relapses.
    Kumar S; Diehn FE; Gertz MA; Tefferi A
    Ann Hematol; 2002 Jun; 81(6):312-9. PubMed ID: 12107560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter prospective study on the treatment of chronic idiopathic thrombocytopenic purpura.
    Dan K; Gomi S; Kuramoto A; Maekawa T; Nomura T
    Int J Hematol; 1992 Jun; 55(3):287-92. PubMed ID: 1498319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for successful laparoscopic splenectomy in patients with immune thrombocytopenic purpura.
    Duperier T; Brody F; Felsher J; Walsh RM; Rosen M; Ponsky J
    Arch Surg; 2004 Jan; 139(1):61-6; discussion 66. PubMed ID: 14718278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
    Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
    Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.